These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

849 related items for PubMed ID: 16163707

  • 1. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 15; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 5. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX, Fang JY, Lu J, Qiu DK.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):312-7. PubMed ID: 15059516
    [Abstract] [Full Text] [Related]

  • 6. Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells.
    Tani M, Ito J, Nishioka M, Kohno T, Tachibana K, Shiraishi M, Takenoshita S, Yokota J.
    Genes Chromosomes Cancer; 2004 Jun 17; 40(2):146-51. PubMed ID: 15101048
    [Abstract] [Full Text] [Related]

  • 7. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 8. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 9. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 10. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines.
    Ou JN, Torrisani J, Unterberger A, Provençal N, Shikimi K, Karimi M, Ekström TJ, Szyf M.
    Biochem Pharmacol; 2007 May 01; 73(9):1297-307. PubMed ID: 17276411
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 13. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H.
    Invest Ophthalmol Vis Sci; 2010 Feb 01; 51(2):679-85. PubMed ID: 19737884
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S, Fields CR, Su N, Pan YX, Robertson KD.
    Oncogene; 2007 Apr 19; 26(18):2621-34. PubMed ID: 17043644
    [Abstract] [Full Text] [Related]

  • 15. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.
    Grassi G, Maccaroni P, Meyer R, Kaiser H, D'Ambrosio E, Pascale E, Grassi M, Kuhn A, Di Nardo P, Kandolf R, Küpper JH.
    Carcinogenesis; 2003 Oct 19; 24(10):1625-35. PubMed ID: 12869421
    [Abstract] [Full Text] [Related]

  • 16. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F, Wolffe AP.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4990-5. PubMed ID: 11309512
    [Abstract] [Full Text] [Related]

  • 17. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
    Liu Y, Hong Y, Zhao Y, Ismail TM, Wong Y, Eu KW.
    Cancer Invest; 2008 Jul 24; 26(6):575-82. PubMed ID: 18584348
    [Abstract] [Full Text] [Related]

  • 18. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 24; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

  • 19. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.
    Oncogene; 2003 Jul 17; 22(29):4509-16. PubMed ID: 12881707
    [Abstract] [Full Text] [Related]

  • 20. Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification.
    Hiroi H, Christenson LK, Strauss JF.
    Mol Cell Endocrinol; 2004 Feb 27; 215(1-2):119-26. PubMed ID: 15026184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.